Dr. Omeed Darweesh is a lecturer at Al-Kitab University, specializing in molecular and cell biology, cancer research, COVID-19 studies, and antimicrobial resistance research. He earned a Bachelor of Pharmaceutical Science from the University of Baghdad, Iraq, before obtaining a PhD in Molecular and Cell Biology from the University of Leicester. Dr. Darweesh has contributed to several research publications. Notably, a study assessing COVID-19 vaccination among healthcare workers in Iraq, focusing on adverse effects and hesitancy, published in PLOS One in 2022. Another significant work is his 2021 article in the Journal of Cell Science, which identifies a novel Bax–Cdk1 signaling complex linking the activation of the mitotic checkpoint to apoptosis. Dr. Darweesh has also published in Oncogene, notably his paper "CREB1-BCL2 drives mitochondrial resilience in RAS GAP-dependent breast cancer chemoresistance" (Oncogene, 2025), which discusses the CREB1-BCL2 pathway's role in chemoresistance in breast cancer cells.
Al-Kitab University
Kirkuk, Kirkūk, Iraq
Faculty of Pharmacy